Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder

GRM7, the gene encoding metabotropic glutamate receptor 7 (mGluR7), have been implicated in multiple neuropsychiatric disorders and shown to mediate excitatory synaptic neurotransmitter signaling and plasticity in the mammalian brain. Here we report a 303 kb de novo deletion at band 3p26.1, disrupting five coding exons of GRM7 in a proband with autism spectrum disorder, and hyperactivity. Our exon transcriptome‐mutation contingency index method shows that three of the exons within the breakpoint boundaries are under purifying selection and highly expressed in prenatal brain regions. Based on our results and a thorough review of the literature, we propose that haploinsufficiency of the GRM7 product (mGluR7) contributes to autism spectrum disorders and hyperactivity phenotype as seen in the patient described here. © 2015 Wiley Periodicals, Inc.

[1]  Colleen M Niswender,et al.  Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications. , 2014, Cellular signalling.

[2]  Pinchen Yang,et al.  Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets. , 2014, Current pharmaceutical design.

[3]  Thomas Bourgeron,et al.  The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism , 2014, Nature Communications.

[4]  Daniele Merico,et al.  Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder , 2014, Nature Genetics.

[5]  Bung-Nyun Kim,et al.  The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorder. , 2014, Journal of child and adolescent psychopharmacology.

[6]  H. Gurling,et al.  Allelic Association, DNA Resequencing and Copy Number Variation at the Metabotropic Glutamate Receptor GRM7 Gene Locus in Bipolar Disorder , 2014, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[8]  M. Fendt,et al.  Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior♦ , 2014, The Journal of Biological Chemistry.

[9]  À. Bayés,et al.  Glutamate receptor mutations in psychiatric and neurodevelopmental disorders , 2014, Communicative & integrative biology.

[10]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[11]  Valsamma Eapen,et al.  Exploring Links between Genotypes, Phenotypes, and Clinical Predictors of Response to Early Intensive Behavioral Intervention in Autism Spectrum Disorder , 2013, Front. Hum. Neurosci..

[12]  D. Hoyer,et al.  Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse , 2013, Neuropharmacology.

[13]  M. Fendt,et al.  Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology , 2013, Neuropharmacology.

[14]  A. Serretti,et al.  Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D , 2013, European Neuropsychopharmacology.

[15]  S. Scherer,et al.  Autism spectrum disorder in the genetics clinic: a review , 2013, Clinical genetics.

[16]  D. Manahan‐Vaughan,et al.  Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning , 2013, Neuropharmacology.

[17]  You Yang,et al.  Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. , 2013, Life sciences.

[18]  Michael E. Greenberg,et al.  Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.

[19]  Jung-Woo Son,et al.  Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample , 2013, Behavioral and Brain Functions.

[20]  WeiQiang Liu,et al.  [Analysis of de novo copy number variations in a family affected with autism spectrum disorders using high-resolution array-based comparative genomic hybridization]. , 2012, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[21]  U. Rajamma,et al.  Glutamate mediated signaling in the pathophysiology of autism spectrum disorders , 2012, Pharmacology Biochemistry and Behavior.

[22]  Zhen Yan,et al.  Regulation of N-Methyl-d-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7*♦ , 2012, The Journal of Biological Chemistry.

[23]  Susanne Walitza,et al.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.

[24]  Geraldine Dawson,et al.  Risk factors for autism: translating genomic discoveries into diagnostics , 2011, Human Genetics.

[25]  F. Nicoletti,et al.  Metabotropic glutamate receptors: From the workbench to the bedside , 2011, Neuropharmacology.

[26]  S. Purcell,et al.  Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample , 2011, European Journal of Human Genetics.

[27]  J. Cryan,et al.  Metabotropic glutamate receptor 7: at the interface of cognition and emotion. , 2010, European journal of pharmacology.

[28]  P. Conn,et al.  Metabotropic glutamate receptors: physiology, pharmacology, and disease. , 2010, Annual review of pharmacology and toxicology.

[29]  C. Bennett,et al.  RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. , 2010, Annual review of pharmacology and toxicology.

[30]  W. Maier,et al.  A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population. , 2009, The international journal of neuropsychopharmacology.

[31]  J. Knowles,et al.  Novel loci for major depression identified by genome-wide association study of STAR*D and meta-analysis of three studies , 2009, Molecular Psychiatry.

[32]  V. Sheffield,et al.  Novel copy number variants in children with autism and additional developmental anomalies , 2009, Journal of Neurodevelopmental Disorders.

[33]  Y. Fukumaki,et al.  Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia , 2009, Psychiatry Research.

[34]  B. Neale,et al.  Genome‐wide association study of response to methylphenidate in 187 children with attention‐deficit/hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  M. Fendt,et al.  mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity , 2008, Molecular Psychiatry.

[36]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[37]  M. Itokawa,et al.  A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia , 2008, Schizophrenia Research.

[38]  R. D'Hooge,et al.  Concomitant Deficits in Working Memory and Fear Extinction Are Functionally Dissociated from Reduced Anxiety in Metabotropic Glutamate Receptor 7-Deficient Mice , 2006, The Journal of Neuroscience.

[39]  P. Kelly,et al.  Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 , 2003, The European journal of neuroscience.

[40]  H. L. Schulz,et al.  Characterization of three novel isoforms of the metabotrobic glutamate receptor 7 (GRM7) , 2002, Neuroscience Letters.

[41]  S. Nakanishi,et al.  Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Deficit in Fear Response and Conditioned Taste Aversion , 1999, The Journal of Neuroscience.

[42]  D. Schoepp,et al.  Metabotropic glutamate receptors , 1994, Pharmacology Biochemistry and Behavior.

[43]  Y. Shinoda,et al.  Animal models of autism spectrum disorder (ASD): a synaptic-level approach to autistic-like behavior in mice. , 2013, Experimental animals.

[44]  J. Potash,et al.  Novel loci for major depression identified by genome-wide association study of STAR*D and meta-analysis of three studies , 2009, Molecular Psychiatry.